Howard C. Dittrich
Gründer bei Advanced Endovascular Therapeutics, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Randall E. Woods | M | 72 |
NovaCardia, Inc.
 NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA.
Sequel Pharmaceuticals, Inc.
 Sequel Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Sequel Pharmaceuticals, Inc. engaged in the development of cardiovascular drug. The company was founded in 2007 and was headquartered in San Diego, CA.
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | 20 Jahre |
| Robert F. Baltera | M | 58 |
Laguna Pharmaceuticals, Inc.
 Laguna Pharmaceuticals, Inc. BiotechnologyHealth Technology Laguna Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. Its lead product, Vanoxerine is a therapeutic candidate being developed for treatment of atrial fibrillation and atrial flutter. The firm’s product is a potential pharmaceutical option to rapidly terminate atrial fibrillation in both hospital and home settings. The company was founded in 2006 by Arthur M. Brown and Howard C. Dittrich and is headquartered in Cleveland, OH.
Cirius Therapeutics, Inc.
 Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | 8 Jahre |
| Brian K. Farmer | M | - |
Sequel Pharmaceuticals, Inc.
Sequel Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Sequel Pharmaceuticals, Inc. engaged in the development of cardiovascular drug. The company was founded in 2007 and was headquartered in San Diego, CA.
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA.
Laguna Pharmaceuticals, Inc.
Laguna Pharmaceuticals, Inc. BiotechnologyHealth Technology Laguna Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. Its lead product, Vanoxerine is a therapeutic candidate being developed for treatment of atrial fibrillation and atrial flutter. The firm’s product is a potential pharmaceutical option to rapidly terminate atrial fibrillation in both hospital and home settings. The company was founded in 2006 by Arthur M. Brown and Howard C. Dittrich and is headquartered in Cleveland, OH.
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | 9 Jahre |
| Dennis Fenton | M | 72 |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | 6 Jahre |
| Julie Iwashita | F | - |
Laguna Pharmaceuticals, Inc.
Laguna Pharmaceuticals, Inc. BiotechnologyHealth Technology Laguna Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. Its lead product, Vanoxerine is a therapeutic candidate being developed for treatment of atrial fibrillation and atrial flutter. The firm’s product is a potential pharmaceutical option to rapidly terminate atrial fibrillation in both hospital and home settings. The company was founded in 2006 by Arthur M. Brown and Howard C. Dittrich and is headquartered in Cleveland, OH.
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA.
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | 5 Jahre |
| Jerry Colca | M | - |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | 9 Jahre |
| Daniel J. Estes | M | 43 |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | 7 Jahre |
| David van Andel | M | 64 |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | 8 Jahre |
| Nilesh Kumar | M | 47 |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | 7 Jahre |
| Robert Zerbe | M | 73 |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | 8 Jahre |
| John Snyder | M | - |
Laguna Pharmaceuticals, Inc.
Laguna Pharmaceuticals, Inc. BiotechnologyHealth Technology Laguna Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. Its lead product, Vanoxerine is a therapeutic candidate being developed for treatment of atrial fibrillation and atrial flutter. The firm’s product is a potential pharmaceutical option to rapidly terminate atrial fibrillation in both hospital and home settings. The company was founded in 2006 by Arthur M. Brown and Howard C. Dittrich and is headquartered in Cleveland, OH.
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | - |
| Mike J. Jandernoa | M | 73 |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | 8 Jahre |
| Brian Finck | M | - |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | 9 Jahre |
| Marsha Chandler | M | 79 |
University of California San Diego
| 27 Jahre |
| Sanjiv M. Narayan | M | - |
University of California San Diego
| 16 Jahre |
| William Sandborn | M | 61 |
University of California San Diego
| 13 Jahre |
| Andrew Knudten | M | - |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | 5 Jahre |
| Angeline K. Shashlo | F | - |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Cirius Therapeutics, Inc. operates as a biotechnology company. It offers metabolic treatment for nonalcoholic steatohepatitis. The company was founded by Jerry R. Colca and Brian Finck and was founded in March 2017, and is headquartered in San Diego, CA. | - |
| Tony Chou | M | 63 |
University of California San Diego
| 30 Jahre |
| C. Lowell Parsons | M | 78 |
University of California San Diego
| 36 Jahre |
| Lin-Tsing Yu | M | 80 |
University of California San Diego
| 30 Jahre |
| David G. Lowe | M | 67 |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | 18 Jahre |
| Michael Karin | M | - |
University of California San Diego
| 38 Jahre |
| Dennis A. Carson | M | 77 |
University of California San Diego
| 34 Jahre |
| Ronald L. Graham | M | 88 |
University of California San Diego
| 25 Jahre |
| Robert W. Conn | M | 81 |
University of California San Diego
| 20 Jahre |
| Lawrence B. Krause | M | 93 |
University of California San Diego
| 38 Jahre |
| Gordon Hanson | M | 60 |
University of California San Diego
| 23 Jahre |
| Richard Feinberg | M | 76 |
University of California San Diego
| 28 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Patrick Keran | M | 52 |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 9 Jahre |
| Steven Mickelsen | M | - |
Farapulse, Inc.
 Farapulse, Inc. Medical SpecialtiesHealth Technology Farapulse, Inc. engages in the development of medical devices. Its products are: Endo Farawave, a percutaneous catheter designed to create transmural and contiguous lesions on the endocardium of the left atrium to isolate the pulmonary veins and EPI Faraone, s designed to create a box lesion around all pulmonary veins from an epicardial placement of the catheter for the treatment of atrial fibrillation. The company was founded by Steven Mickelsen in 2014 and is headquartered in Iowa City, IA. | 4 Jahre |
| Brandi Roberts | F | 50 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 6 Jahre |
| Eckard Weber | M | 73 |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | 6 Jahre |
| Salman Khetani | M | - |
University of California San Diego
| 6 Jahre |
| Bobba Venkatadri | M | 79 |
Molecular Biosystems, Inc.
 Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | 5 Jahre |
| Brenda Turner | F | - |
University of California San Diego
| 6 Jahre |
| Thomas O'Neil | M | 59 |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Glenn Joseph Busch | M | - |
University of California San Diego
| 8 Jahre |
| Yu Shi Shen | M | 46 |
University of California San Diego
| 3 Jahre |
| Ellen Chen | F | - |
University of California San Diego
| 4 Jahre |
| Elizabeth Hougen | F | 62 |
Molecular Biosystems, Inc.
Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | 8 Jahre |
| William O'Connor | M | - |
University of California San Diego
| 5 Jahre |
| Jeffrey Stein | M | 69 |
University of California San Diego
| 5 Jahre |
| Eric Apaydin | M | - |
University of California San Diego
| 5 Jahre |
| Dan Mytels | M | - |
University of California San Diego
| 5 Jahre |
| Richard Castle | M | - |
University of California San Diego
| 4 Jahre |
| Arthur M. Brown | M | - |
Laguna Pharmaceuticals, Inc.
Laguna Pharmaceuticals, Inc. BiotechnologyHealth Technology Laguna Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. Its lead product, Vanoxerine is a therapeutic candidate being developed for treatment of atrial fibrillation and atrial flutter. The firm’s product is a potential pharmaceutical option to rapidly terminate atrial fibrillation in both hospital and home settings. The company was founded in 2006 by Arthur M. Brown and Howard C. Dittrich and is headquartered in Cleveland, OH. | - |
| Sau Kuen Yu | F | 48 |
University of California San Diego
| 5 Jahre |
| Tony Craddock | M | - |
University of California San Diego
| 8 Jahre |
| Mark Mugerditchian | M | - |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA.
Laguna Pharmaceuticals, Inc.
Laguna Pharmaceuticals, Inc. BiotechnologyHealth Technology Laguna Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. Its lead product, Vanoxerine is a therapeutic candidate being developed for treatment of atrial fibrillation and atrial flutter. The firm’s product is a potential pharmaceutical option to rapidly terminate atrial fibrillation in both hospital and home settings. The company was founded in 2006 by Arthur M. Brown and Howard C. Dittrich and is headquartered in Cleveland, OH. | - |
| Lloyd Rowland | M | 67 |
Alliance Pharmaceutical Corp.
 Alliance Pharmaceutical Corp. BiotechnologyHealth Technology Alliance Pharmaceutical Corp. is a research & development company, which focused on transformed innovative scientific discovered into novel therapeutic and diagnostic agents. It currently focused on developed its lead product, Oxygent, an intravascular oxygen carrier designed to augment oxygen deliveryed in surgical patients. The company was founded by Duane J. Roth in 1983 and is headquartered in San Diego, CA. | 8 Jahre |
| David Ramsay | M | 59 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 6 Jahre |
| Franklin J. Miller | M | 83 |
University of California San Diego
| 9 Jahre |
| Bob Whiton | M | - |
University of California San Diego
| 5 Jahre |
| Lewis J. Shuster | M | 68 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 5 Jahre |
| Jack Lief | M | 78 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 9 Jahre |
| Peter Greenleaf | M | 54 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | - |
| Stefan Loren | M | 60 |
University of California San Diego
| 11 Jahre |
| Emily Warren | F | - |
University of California San Diego
| 4 Jahre |
| Ed Ruth | M | - |
University of California San Diego
| 4 Jahre |
| Kevin Sutantyo | M | - |
University of California San Diego
| 4 Jahre |
| Ksenia Koban | F | - |
University of California San Diego
| 4 Jahre |
| Kang Man Wong | M | 40 |
University of California San Diego
| 4 Jahre |
| Arcediano jason | M | - |
University of California San Diego
| 5 Jahre |
| Scott Moonly | M | - |
University of California San Diego
| 5 Jahre |
| Silvia Mah | M | - |
University of California San Diego
| 7 Jahre |
| Akash Bakshi | M | 35 |
University of California San Diego
| 4 Jahre |
| Tyler Korman | M | 45 |
University of California San Diego
| 4 Jahre |
| Marcos Rivera | M | - |
University of California San Diego
| 4 Jahre |
| Rachel Wu | F | 41 |
University of California San Diego
| 4 Jahre |
| Sagnik Nandy | M | - |
University of California San Diego
| 4 Jahre |
| Xiaohan Zhu | M | - |
University of California San Diego
| 2 Jahre |
| Peter Heller Finkel | M | - |
University of California San Diego
| 4 Jahre |
| Wilson Greg | M | - |
University of California San Diego
| 5 Jahre |
| Paul-Peter Tak | M | 64 |
University of California San Diego
| 5 Jahre |
| Tim Liu | M | - |
University of California San Diego
| 4 Jahre |
| Conrad Hummel | M | - |
University of California San Diego
| 3 Jahre |
| Xuhui Shao | M | - |
University of California San Diego
| 2 Jahre |
| Blake Schneider | M | - |
University of California San Diego
| 4 Jahre |
| Lawrence Alan Taylor | M | - |
University of California San Diego
| 5 Jahre |
| Marsha Otto Riley | F | - |
University of California San Diego
| 2 Jahre |
| Jason Daniel Kantor | M | - |
University of California San Diego
| 4 Jahre |
| Kevin D. Blair | M | - |
University of California San Diego
| 4 Jahre |
| Gary Seelhorst | M | 52 |
University of California San Diego
| 4 Jahre |
| Mitch J. Zeitz | M | - |
University of California San Diego
| 4 Jahre |
| Andreas Brandstetter | M | 55 |
University of California San Diego
| 3 Jahre |
| Walter Luyten | M | - |
University of California San Diego
| 3 Jahre |
| Reyhaneh Zand | F | - |
University of California San Diego
| 4 Jahre |
| Randolph Simpson | M | 55 |
University of California San Diego
| 4 Jahre |
| Sangeeta Bhatia | M | 55 |
University of California San Diego
| 7 Jahre |
| Jeff Daems | M | - |
University of California San Diego
| 4 Jahre |
| Kirstin Kriz | M | 49 |
University of California San Diego
| 4 Jahre |
| Dev K. Mishra | M | - |
University of California San Diego
| 3 Jahre |
| Reid Tomlin | M | - |
University of California San Diego
| 4 Jahre |
| Daniel Riskin | M | - |
University of California San Diego
| 5 Jahre |
| Beatriz Acevedo-Greiff | F | - |
University of California San Diego
| 4 Jahre |
| Ross Trejo Locher | M | - |
University of California San Diego
| 4 Jahre |
| Anthony Di Leva | M | - |
University of California San Diego
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 98 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Howard C. Dittrich
- Persönliches Netzwerk